

Overview
In this lecture, Professor Kwong Yok Lam introduced the current situation, including the challenges and opportunities of using CAR-T cell therapy in Hong Kong; Professor Pier Luigi Zinzani showed the real-world evidence of CAR-T therapy in managing non-Hodgkin lymphoma from Europe; Dr Thomas Chan shared his experiences in selecting patients for CAR-T therapy and strategies for optimizing patient outcomes via two cases.
Upon completion of this module, participants will be able to: